Research graph
References from Urinary Soluble Collagen Levels Are Associated With Moderate/Severe LUTS. Local targets link to admitted publications; unresolved targets remain external evidence.
The Global, Regional, and National Burden of Benign Prostatic Hyperplasia in 204 Countries and Territories From 2000 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019
10.1016/s2666-7568(22)00213-6 · 2022 · External reference
The Epidemiology of Benign Prostatic Hyperplasia Associated With Lower Urinary Tract Symptoms
10.1016/j.ucl.2016.04.001 · 2016 · External reference
Medical Management of Lower Urinary Tract Symptoms
2009 · External reference
A Review of Combination Therapy in Patients With Benign Prostatic Hyperplasia
10.1016/s0149-2918(07)80077-4 · 2007 · External reference
Tadalafil Alone or in Combination With Tamsulosin for the Management for LUTS/BPH and ED
10.1007/s11934-020-01009-7 · 2020 · External reference
BPH Update: Medical Versus Interventional Management
2016 · External reference
Prostatic Fibrosis, Lower Urinary Tract Symptoms, and BPH
10.1038/nrurol.2013.149 · 2013 · External reference
Prostate Transition Zone Fibrosis Is Associated With Clinical Progression in the MTOPS Study
10.1097/ju.0000000000000385 · 2019 · External reference
Collagen in Fibrotic Diseases
10.1007/978-3-032-05273-5_11 · 2026 · External reference
Collagen Mechanics
10.1007/978-3-032-05273-5_10 · 2026 · External reference
Baseline Lower Urinary Tract Symptoms in Patients Enrolled in LURN: A Prospective, Observational Cohort Study
10.1016/j.juro.2017.10.035 · 2018 · External reference
Lower Urinary Tract Stenosis Following Surgery for Benign Prostatic Hyperplasia
10.1007/s11934-021-01070-w · 2021 · External reference
Transurethral Resection of the Prostate Stricture Management
10.4103/aja.aja_126_19 · 2020 · External reference
Post‐Transurethral Resection of Prostate Urethral Strictures: Are They Often Underreported? A Single‐Center Retrospective Observational Cohort Study
10.4103/ua.ua_165_19 · 2021 · External reference
CE‐MS‐Based Urinary Biomarkers to Distinguish Non‐Significant From Significant Prostate Cancer
10.1038/s41416-019-0472-z · 2019 · External reference
Mass Spectrometry‐Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non‐Invasive Urine Collection Without Prior Digital Rectal Examination
10.3390/cancers15041166 · 2023 · External reference
Prostate Cancer‐Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip
10.3390/ijms27031585 · 2026 · External reference
Heterogeneity of Human Prostate Carcinoma‐Associated Fibroblasts Implicates a Role for Subpopulations in Myeloid Cell Recruitment
10.1002/pros.23929 · 2020 · External reference
Prostate‐Specific Antigen and Other Serum and Urine Markers in Prostate Cancer
10.1016/j.bbcan.2014.04.001 · 2014 · External reference
A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways That Associate With Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study
10.1016/j.urology.2019.03.014 · 2019 · External reference
Circulating Proteomic Signatures of Chronological Age
2015 · External reference
Renal Aging and Fibrosis in the Elderly: Frontiers in Non‐Invasive Assessment
2026 · External reference
